Target price is 126/423.60%.
MODERNA(MRNA) CHART 071420
Category: MODERNA – MRNA
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 850
http://www.modernatx.com
Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019 the company had 11 programs in clinical trials and a total of 20 development candidates in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca, Merck & Co., Vertex Pharmaceuticals, Biomedical Advanced Research and Development Authority, Defense Advanced Research Projects Agency, and Bill & Melinda Gates Foundation; and a research collaboration with Harvard University. Moderna, Inc. also has a collaboration with Lonza Ltd. for the manufacture of mRNA-1273, a COVID-19 vaccine. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
MODERNA(MRNA) CHART 061820
Target price is 91/423.60%.
MODERNA(MRNA) CHART 061120
Target number is 91/423.60%.
MODERNA CHART 052220
Stopped at double support level at 65. Target price will be 90/423.60%. If support fail this will go down next support level at 50.
15 min chart. Uptrend. If fall, check below support levels.